What is this study trying to find out about cancer risk?

This study aims to collect biological samples and related data from patients with or at risk of cancer to improve cancer care. Researchers hope to support new trials, technology, and personalized medicine. The University of Colorado, Denver sponsors this research to help advance treatment options for cancer patients.

Who may be eligible for this cancer risk clinical trial?

Adults 18 years and older diagnosed with cancer or at risk for cancer may be eligible to participate. Participants must be able to understand and sign consent forms or have a legal representative to do so. This study is open to all genders. Please review eligibility criteria for more details.

Is there any cost to participate in this cancer risk clinical trial?

Study-related care, including sample collection and data review, is provided at no cost. However, personal travel and other expenses are not guaranteed to be covered and may vary by participant.

Actively Recruiting

Age: 18Years +

All Genders

ID03617939

A Lifetime Partnership to Collect Biological Samples and Data from Adults With or at Risk of Cancer for Improving Cancer Care

Led by University of Colorado, Denver · Updated on 2025-11-10

20000

Participants Needed

Research Sites

104 weeks

Total Duration

AI-Summary

What this Trial Is About

Researchers are studying patients who have cancer or may be at risk of developing cancer to improve the standard of care. This observational study collects blood, tissue, and other biological samples along with associated data such as surveys, medical records, and cancer registry information. The goal is to enable new clinical trials, technology advancements, and personalized medicine for cancer patients over time. Participants provide consent to allow collection and storage of their biological samples and data. This includes blood and tissue samples as well as survey assessments and medical chart reviews. The study does not involve treatment but focuses on gathering information to support cancer research and care improvements. During the study, patients biological samples and data are collected and stored long-term. Researchers analyze survey responses, medical records, and biological specimens to measure outcomes related to improving cancer care standards. The study follows participants for up to 20 years, aiming for a lifetime partnership to support ongoing cancer research and care advancements.

CONDITIONS

Brief Title

A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

Who Can Participate

Age: 18Years +

All Genders

Eligibility Criteria

You may qualify if you...

18 years of age and older
Diagnosed with cancer or may be at risk for cancer
Able to understand and sign the informed consent and research authorization form directly or through a legally authorized representative
Non-English speaking individuals may participate using a short-form consent process

You will not qualify if you...

Members of vulnerable populations including neonates (birth to 30 days), children under 18 years
Wards of the State
Prisoners or those on probation or alternate sentencing
Adults or children who are cognitively impaired, incompetent to consent, or require proxy consent in life-threatening situations
Decisionally challenged individuals unable to provide consent themselves

Research Team

Kyra Anderson

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here